Essential roles of gangliosides in the formation and maintenance of membrane microdomains in brain tissues - PubMed (original) (raw)
Review
. 2012 Jun;37(6):1185-91.
doi: 10.1007/s11064-012-0764-7. Epub 2012 Apr 10.
Affiliations
- PMID: 22488331
- DOI: 10.1007/s11064-012-0764-7
Review
Essential roles of gangliosides in the formation and maintenance of membrane microdomains in brain tissues
Yuhsuke Ohmi et al. Neurochem Res. 2012 Jun.
Abstract
Gangliosides are considered to be involved in the maintenance and repair of nervous tissues. Recently, novel roles of gangliosides in the regulation of complement system were reported. Here we summarized roles of gangliosides in the formation and maintenance of membrane microdomains in brain tissues by comparing complement activation, inflammatory reaction and disruption of glycolipid-enriched microdomain (GEM)/rafts among several mutant mice of ganglioside synthases. Depending on the defects in ganglioside compositions, corresponding up-regulation of complement-related genes, proliferation of astrocytes and infiltration of microglia were found with gradual severity. Immunoblotting of fractions separated by sucrose density gradient ultracentrifugation revealed that DAF and NCAM having GPI-anchors tended to disappear from the raft fraction with intensities of DKO > GM2/GD2 synthase KO > GD3 synthase KO > WT. The lipid raft markers tended to disperse from the raft fractions with similar intensities. Phospholipids and cholesterol also tended to decrease in GEM/rafts in GM2/GD2 synthase KO and DKO, although total amounts were almost equivalent. All these results indicate that GEM/rafts architecture is destroyed by ganglioside deficiency with gradual intensity depending on the degree of defects of their compositions. Implication of inflammation caused by deficiency of gangliosides in various neurodegenerative diseases was discussed.
Similar articles
- Gangliosides are essential in the protection of inflammation and neurodegeneration via maintenance of lipid rafts: elucidation by a series of ganglioside-deficient mutant mice.
Ohmi Y, Tajima O, Ohkawa Y, Yamauchi Y, Sugiura Y, Furukawa K, Furukawa K. Ohmi Y, et al. J Neurochem. 2011 Mar;116(5):926-35. doi: 10.1111/j.1471-4159.2010.07067.x. Epub 2011 Jan 12. J Neurochem. 2011. PMID: 21214571 - Gangliosides play pivotal roles in the regulation of complement systems and in the maintenance of integrity in nerve tissues.
Ohmi Y, Tajima O, Ohkawa Y, Mori A, Sugiura Y, Furukawa K, Furukawa K. Ohmi Y, et al. Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22405-10. doi: 10.1073/pnas.0912336106. Epub 2009 Dec 11. Proc Natl Acad Sci U S A. 2009. PMID: 20018737 Free PMC article. - Ganglioside deficiency causes inflammation and neurodegeneration via the activation of complement system in the spinal cord.
Ohmi Y, Ohkawa Y, Tajima O, Sugiura Y, Furukawa K, Furukawa K. Ohmi Y, et al. J Neuroinflammation. 2014 Mar 28;11:61. doi: 10.1186/1742-2094-11-61. J Neuroinflammation. 2014. PMID: 24673754 Free PMC article. - Gangliosides in Inflammation and Neurodegeneration.
Furukawa K, Ohmi Y, Tajima O, Ohkawa Y, Kondo Y, Shuting J, Hashimoto N, Furukawa K. Furukawa K, et al. Prog Mol Biol Transl Sci. 2018;156:265-287. doi: 10.1016/bs.pmbts.2018.01.009. Epub 2018 Apr 10. Prog Mol Biol Transl Sci. 2018. PMID: 29747817 Review. - Regulatory mechanisms of nervous systems with glycosphingolipids.
Furukawa K, Ohmi Y, Ohkawa Y, Tokuda N, Kondo Y, Tajima O, Furukawa K. Furukawa K, et al. Neurochem Res. 2011 Sep;36(9):1578-86. doi: 10.1007/s11064-011-0494-2. Epub 2011 May 12. Neurochem Res. 2011. PMID: 21562747 Review.
Cited by
- Ganglioside accumulation in activated glia in the developing brain: comparison between WT and GalNAcT KO mice.
Saito M, Wu G, Hui M, Masiello K, Dobrenis K, Ledeen RW, Saito M. Saito M, et al. J Lipid Res. 2015 Aug;56(8):1434-48. doi: 10.1194/jlr.M056580. Epub 2015 Jun 10. J Lipid Res. 2015. PMID: 26063460 Free PMC article. - The Structural Diversity of Natural Glycosphingolipids (GSLs).
Guo Z. Guo Z. J Carbohydr Chem. 2022;41(2-3):63-154. doi: 10.1080/07328303.2022.2063308. Epub 2022 May 26. J Carbohydr Chem. 2022. PMID: 36561362 Free PMC article. - GD3 ganglioside is a promising therapeutic target for glioma patients.
Hein V, Baeza-Kallee N, Bertucci A, Colin C, Tchoghandjian A, Figarella-Branger D, Tabouret E. Hein V, et al. Neurooncol Adv. 2024 Mar 19;6(1):vdae038. doi: 10.1093/noajnl/vdae038. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38590763 Free PMC article. Review. - Who's in, who's out? Re-evaluation of lipid raft residents.
Mlinac-Jerkovic K, Ilic K, Zjalić M, Mandić D, Debeljak Ž, Balog M, Damjanović V, Maček Hrvat N, Habek N, Kalanj-Bognar S, Schnaar RL, Heffer M. Mlinac-Jerkovic K, et al. J Neurochem. 2021 Aug;158(3):657-672. doi: 10.1111/jnc.15446. Epub 2021 Jun 28. J Neurochem. 2021. PMID: 34081780 Free PMC article. - Gangliosides and Neuroblastomas.
Schengrund CL. Schengrund CL. Int J Mol Sci. 2020 Jul 27;21(15):5313. doi: 10.3390/ijms21155313. Int J Mol Sci. 2020. PMID: 32726962 Free PMC article. Review.
References
- Nat Rev Mol Cell Biol. 2010 Oct;11(10):688-99 - PubMed
- Behav Brain Res. 2009 Mar 2;198(1):74-82 - PubMed
- J Immunol. 2003 Jun 1;170(11):5764-71 - PubMed
- Neuroscience. 2005;135(4):1167-78 - PubMed
- Biochim Biophys Acta. 2006 May-Jun;1761(5-6):588-98 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous